Although U.S. venture capital funding for the life science sector dropped by 15 percent in the third quarter of 2013, PricewaterhouseCoopers executives say that they are expecting investment within the industry to return. A new report, Falling Behind, includes data from MoneyTree Report from PwC and the National Venture Capital Association based on data provided by Thomson Reuters By Mia Burns (firstname.lastname@example.org)
We never really know where the next game-changing innovation will come from. The smartphone started out as just that — a smarter phone. But when Apple opened up its API to developers, that open source project started to unlock the true potential of a handheld, connected touchscreen computer. Nowadays, the ability to make a phone call might just be the least important thing your smartphone does for you.
In the next few years, we might be saying something similar about the Microsoft Kinect, which has a similarly open software development kit. What began as a video game controller is rapidly becoming much more, as developers turn the power of computerized gesture recognition onto a bevy of healthcare uses.
LONDON (Reuters) - GlaxoSmithKline raised its bet on using electrical signals in the body to target diseases on Thursday with the launch of a $50 million strategic venture capital fund.Britain's biggest...
An interesting thing happened on the way through 2013: Biotechnology venture investing began to see a healthy rebound in the second quarter, but medical device investing stayed essentially flat compared to the first three months of the year.
At EyeNetra, the startup he cofounded, goofy curiosities like plastic eyeballs line the shelves, and a 3-D printing machine whirs in the background. It’s printing out prototypes of a device that will attach to your smartphone and, in a minute or two, tell you what kind of eyeglasses you need.
The device, called the Netra-G, is based on some clever optics and software Pamplona came up with—a way to measure the refractive error of the eye using a smartphone screen and an inexpensive pair of plastic binoculars. The whole setup might cost a few dollars to make. It does the job of a $5,000 instrument called an autorefractor.
More important, just about anyone could use it. That’s where the disruption comes in—and the trouble. Right now, only doctors or optometrists can prescribe glasses or contact lenses. Pamplona, a brash Brazilian programmer who arrived in the U.S. a few years ago, thinks that won’t always be the case. “We’re changing medicine by providing the user the right to measure themselves,” he says. “We see doctors as more of a coach.”
The $2.5 trillion healthcare sector has a problem: accredited investors lack access to some of the most promising biomedical innovations, while compelling healthcare companies are routinely underfunded.
Now that the Supreme Court has decided that human genes can’t be patented, a group of researchers is using high-tech data science to better understand the genetic mutations associated with breast cancer.
Sharing your scoops to your social media accounts is a must to distribute your curated content. Not only will it drive traffic and leads through your content, but it will help show your expertise with your followers.
How to integrate my topics' content to my website?
Integrating your curated content to your website or blog will allow you to increase your website visitors’ engagement, boost SEO and acquire new visitors. By redirecting your social media traffic to your website, Scoop.it will also help you generate more qualified traffic and leads from your curation work.
Distributing your curated content through a newsletter is a great way to nurture and engage your email subscribers will developing your traffic and visibility.
Creating engaging newsletters with your curated content is really easy.